Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 55/100

Failure Rate

25.0%

1 terminated/withdrawn out of 4 trials

Success Rate

75.0%

-11.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

133%

4 of 3 completed trials have results

Key Signals

4 with results

Enrollment Performance

Analytics

N/A
2(100.0%)
2Total
N/A(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT04095039Not ApplicableTerminated

HiLo: Pragmatic Trial of Higher vs Lower Serum Phosphate Targets in Patients Undergoing Hemodialysis

Role: collaborator

NCT02488317Not ApplicableCompleted

Empowering Patients On Choices for Renal Replacement Therapy (Aim 3) (EPOCH-RRT)

Role: collaborator

NCT02440659Completed

Empowering Patients on Choices for Renal Replacement Therapy (Aim 2)

Role: collaborator

NCT01952600Completed

Empowering Patients On Choices for Renal Replacement Therapy (Aim 1)

Role: collaborator

All 4 trials loaded